Armata Pharmaceuticals (ARMP) Operating Leases (2019 - 2026)
Armata Pharmaceuticals (ARMP) posted Operating Leases of $26.2 million for Q1 2026, down 1.32% sequentially from $26.5 million in Q4 2025, and down 4.5% YoY from $27.4 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Operating Leases (2019 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Operating Leases for 8 years, with the latest figure at $26.2 million in Q1 2026.
- Quarterly Operating Leases fell 4.5% year-over-year to $26.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.2 million (down 4.5% YoY) and the FY2025 annual result came in at $26.5 million, down 4.19% from the prior year.
- Operating Leases declined to $26.2 million in Q1 2026 per ARMP's latest filing, from $26.5 million in the prior quarter.
- Over five years, Operating Leases peaked at $37.2 million in Q2 2022 and troughed at $26.2 million in Q1 2026.
- A 5-year average of $29.7 million and a median of $28.2 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2023: Operating Leases surged 251.66% in 2022, then decreased 26.33% in 2023.
- Over 5 years, Operating Leases stood at $31.8 million in 2022, then retreated by 10.13% to $28.6 million in 2023, then dropped by 3.11% to $27.7 million in 2024, then slipped by 4.19% to $26.5 million in 2025, then dropped by 1.32% to $26.2 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $26.2 million, $26.5 million, and $26.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.82 Mn |
| Mar 31, 2026 | 26.18 Mn |
| Dec 31, 2025 | 26.53 Mn |
| Sep 30, 2025 | 26.84 Mn |
| Jun 30, 2025 | 27.13 Mn |
| Mar 31, 2025 | 27.42 Mn |
| Dec 31, 2024 | 27.69 Mn |
| Sep 30, 2024 | 27.93 Mn |
| Jun 30, 2024 | 28.16 Mn |
| Mar 31, 2024 | 28.38 Mn |
| Dec 31, 2023 | 28.58 Mn |
| Sep 30, 2023 | 28.16 Mn |
| Jun 30, 2023 | 27.43 Mn |
| Mar 31, 2023 | 31.84 Mn |
| Dec 31, 2022 | 31.80 Mn |
| Sep 30, 2022 | 37.22 Mn |
| Jun 30, 2022 | 37.23 Mn |
| Mar 31, 2022 | 36.92 Mn |
| Dec 31, 2021 | 36.48 Mn |
| Sep 30, 2021 | 10.59 Mn |